首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
【24h】

Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.

机译:来自原发性骨肉瘤的间充质基质细胞是非恶性的,并且与它们的骨髓类似物惊人地相似。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mesenchymal stromal cells (MSC) are multipotent cells that can be isolated from a number of human tissues. In cancer, MSC have been implicated with tumor growth, invasion, metastasis, drug resistance and were even suggested as possible tumor-initiating cells in osteosarcoma (OS). However, MSC from OS and their possible tumor origin have not yet been thoroughly investigated. Therefore, primary OS mesenchymal progenitors and OS-derived MSC were studied. OS samples contained very high frequencies of mesenchymal progenitor cells as measured by the colony-forming unit fibroblast (CFU-F) assay (median: 1,117 colonies per 10(5) cells, range: 133-3,000, n = 6). This is considerably higher compared to other human tissues such as normal bone marrow (BM) (1.3 +/- 0.2 colonies per 10(5) cells, n = 8). OS-derived MSC (OS-MSC) showed normal MSC morphology and expressed the typical MSC surface marker profile (CD105/CD73/CD90/CD44/HLA-classI/CD166 positive, CD45/CD34/CD14/CD19/HLA-DR/CD31 negative). Furthermore, all OS-MSC samples could be differentiated into the osteogenic lineage, and all but one sample into adipocytes and chondrocytes. Genetic analysis of OS-MSC as well as OS-derived spheres showed no tumor-related chromosomal aberrations. OS-MSC expression of markers related to tumor-associated fibroblasts (fibroblast surface protein, alpha-smooth muscle actin, vimentin) was comparable to BM-MSC and OS-MSC growth was considerably affected by tyrosine kinase inhibitors. Taken together, our results demonstrate that normal, non-malignant mesenchymal stroma cells are isolated from OS when MSC culture techniques are applied. OS-MSC represent a major constituent of the tumor microenvironment, and they share many properties with BM-derived MSC.
机译:间充质基质细胞(MSC)是一种多能细胞,可以从许多人体组织中分离出来。在癌症中,MSC与肿瘤的生长,浸润,转移,耐药性有关,甚至被认为可能是骨肉瘤(OS)中的肿瘤引发细胞。但是,来自OS的MSC及其可能的肿瘤起源尚未得到彻底研究。因此,研究了原发性OS间充质祖细胞和OS来源的MSC。 OS样本包含通过集落形成单位成纤维细胞(CFU-F)分析测量的极高频率的间充质祖细胞(中位数:每10(5)细胞1,117个菌落,范围:133-3,000,n = 6)。与其他人体组织(例如正常骨髓(BM))相比,该比例要高得多(每10(5)个细胞1.3 +/- 0.2个菌落,n = 8)。 OS衍生的MSC(OS-MSC)表现出正常的MSC形态,并表达了典型的MSC表面标记图谱(CD105 / CD73 / CD90 / CD44 / HLA-classI / CD166阳性,CD45 / CD34 / CD14 / CD19 / HLA-DR / CD31负)。此外,所有OS-MSC样品均可分化为成骨谱系,除一个样品外,其余所有样品均可分化为脂肪细胞和软骨细胞。 OS-MSC以及OS衍生球的遗传分析显示,没有与肿瘤相关的染色体畸变。与肿瘤相关的成纤维细胞(成纤维细胞表面蛋白,α-平滑肌肌动蛋白,波形蛋白)相关的标志物的OS-MSC表达与BM-MSC相当,而酪氨酸激酶抑制剂对OS-MSC的生长影响很大。综上所述,我们的结果表明,当应用MSC培养技术时,可以从OS中分离出正常的非恶性间质基质细胞。 OS-MSC代表了肿瘤微环境的主要组成部分,它们与BM来源的MSC具有许多特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号